Literature DB >> 36048214

Compromised activity of natural killer cells in diffuse large b-cell lymphoma is related to lymphoma-induced modification of their surface receptor expression.

Tehila Azoulay1, Ilana Slouzky2, Michal Karmona2, Margarita Filatov2, Michal Hayun1, Yishai Ofran1,3, Galit Sarig4,5, Shimrit Ringelstein-Harlev6,7.   

Abstract

While natural killer (NK) cells are essential players in detection and elimination of malignant cells, these surveillance properties can be compromised by cancer cells. Since NK cell education primarily occurs in the bone marrow and lymphoid tissue, this process might be particularly affected by their infiltration with lymphoma cells. This study aimed to explore functional properties of diffuse large B-cell lymphoma (DLBCL) patient NK cells, which could potentially promote tumour immune evasion and disease propagation.NK cells isolated from the peripheral blood (PB) of 26 DLBCL patients and 13 age-matched healthy controls (HC) were analysed. The cytotoxic CD56dim subtype was the only one identified in patients. Compared to HC, patient cells demonstrated low levels of inhibitory CD158a/b along with decreased expression of activating NKG2D and CD161 and increased inhibitory NKG2A levels. Patient NK cell cytotoxic activity was impaired, as were their degranulation and inflammatory cytokine production, which partially recovered following non-receptor-dependant stimulation.The phenotypically skewed and restricted population of patient NK cells, along with their blunted cytotoxic and immune-regulatory activity, appear to be driven by exposure to lymphoma environment. These NK cell functional aberrations could support lymphoma immune evasion and should be considered in the era of cellular therapy.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cytotoxicity; Diffuse large B-cell lymphoma; Immune evasion; Inflammatory cytokines; Natural killer cells

Year:  2022        PMID: 36048214     DOI: 10.1007/s00262-022-03284-4

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.630


  54 in total

1.  CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets.

Authors:  O Penack; C Gentilini; L Fischer; A M Asemissen; C Scheibenbogen; E Thiel; L Uharek
Journal:  Leukemia       Date:  2005-05       Impact factor: 11.528

Review 2.  NK cell recognition.

Authors:  Lewis L Lanier
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

3.  NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.

Authors:  Mark J Smyth
Journal:  Int Immunol       Date:  2008-03-11       Impact factor: 4.823

4.  Multifunctional human CD56 low CD16 low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients.

Authors:  Helena Stabile; Paolo Nisti; Stefania Morrone; Daria Pagliara; Alice Bertaina; Franco Locatelli; Angela Santoni; Angela Gismondi
Journal:  Haematologica       Date:  2015-01-16       Impact factor: 9.941

5.  Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.

Authors:  M A Cooper; T A Fehniger; S C Turner; K S Chen; B A Ghaheri; T Ghayur; W E Carson; M A Caligiuri
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

Review 6.  Developmental pathways that generate natural-killer-cell diversity in mice and humans.

Authors:  Nicholas D Huntington; Christian A J Vosshenrich; James P Di Santo
Journal:  Nat Rev Immunol       Date:  2007-09       Impact factor: 53.106

7.  Metastatic behavior of human tumor cell lines grown in the nude mouse.

Authors:  J M Kozlowski; I J Fidler; D Campbell; Z L Xu; M E Kaighn; I R Hart
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

8.  Regulation of the metastasis of murine ocular melanoma by natural killer cells.

Authors:  R Harning; G C Koo; J Szalay
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-09       Impact factor: 4.799

Review 9.  NK cells and cancer immunosurveillance.

Authors:  I Waldhauer; A Steinle
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

10.  CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts.

Authors:  Antoni Chan; Deng-Li Hong; Ann Atzberger; Simon Kollnberger; Andrew D Filer; Christopher D Buckley; Andrew McMichael; Tariq Enver; Paul Bowness
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.